HL7 FHIR® Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment)

This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.1.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions

OncotypeDxDCISRiskScoreInterpretationCS

@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:CodeSystem;
  fhir:nodeRole fhir:treeRoot;
  fhir:Resource.id [ fhir:value "oncology-OncotypeDxDCISRiskScoreInterpretationCS"];
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "generated" ];
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p><b>BC OncotypeDxDCISRiskScoreInterpretationCS CodeSystem</b></p>\n<p>Intepretation of OncotypeDX DCIS (Ductal Carcinoma In Situ) Recurrence Score</p>\n</div>"
  ];
  fhir:CodeSystem.url [ fhir:value "http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-OncotypeDxDCISRiskScoreInterpretationCS"];
  fhir:CodeSystem.identifier [
     fhir:Identifier.system [ fhir:value "http://hl7.org/fhir/us/breastcancer" ];
     fhir:Identifier.value [ fhir:value "oncology.OncotypeDxDCISRiskScoreInterpretationCS" ]
  ];
  fhir:CodeSystem.version [ fhir:value "0.1.0"];
  fhir:CodeSystem.name [ fhir:value "OncotypeDxDCISRiskScoreInterpretationCS"];
  fhir:CodeSystem.title [ fhir:value "BC OncotypeDxDCISRiskScoreInterpretationCS CodeSystem"];
  fhir:CodeSystem.status [ fhir:value "draft"];
  fhir:CodeSystem.date [ fhir:value "2018-04-01T00:00:00+11:00"^^xsd:dateTime];
  fhir:CodeSystem.publisher [ fhir:value "The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC)"];
  fhir:CodeSystem.contact [
     fhir:index 0;
     fhir:ContactDetail.telecom [
       fhir:index 0;
       fhir:ContactPoint.system [ fhir:value "url" ];
       fhir:ContactPoint.value [ fhir:value "http://standardhealthrecord.org" ]     ]
  ];
  fhir:CodeSystem.description [ fhir:value "Intepretation of OncotypeDX DCIS (Ductal Carcinoma In Situ) Recurrence Score"];
  fhir:CodeSystem.caseSensitive [ fhir:value "true"^^xsd:boolean];
  fhir:CodeSystem.content [ fhir:value "complete"];
  fhir:CodeSystem.count [ fhir:value "3"^^xsd:nonNegativeInteger];
  fhir:CodeSystem.concept [
     fhir:index 0;
     fhir:CodeSystem.concept.code [ fhir:value "low_risk" ];
     fhir:CodeSystem.concept.display [ fhir:value "Recurrence Score lower than 38: The cancer has a low risk of recurrence. The benefit of chemotherapy is likely to be small and will not outweigh the risks of side effects." ];
     fhir:CodeSystem.concept.definition [ fhir:value "Recurrence Score lower than 38: The cancer has a low risk of recurrence. The benefit of chemotherapy is likely to be small and will not outweigh the risks of side effects." ]
  ], [
     fhir:index 1;
     fhir:CodeSystem.concept.code [ fhir:value "intermediate_risk" ];
     fhir:CodeSystem.concept.display [ fhir:value "Recurrence Score of 39 up to and including 54: The cancer has an intermediate risk of recurrence. It’s unclear whether the benefits of chemotherapy outweigh the risks of side effects." ];
     fhir:CodeSystem.concept.definition [ fhir:value "Recurrence Score of 39 up to and including 54: The cancer has an intermediate risk of recurrence. It’s unclear whether the benefits of chemotherapy outweigh the risks of side effects." ]
  ], [
     fhir:index 2;
     fhir:CodeSystem.concept.code [ fhir:value "high_risk" ];
     fhir:CodeSystem.concept.display [ fhir:value "Recurrence Score greater than or equal to 55: The cancer has a high risk of recurrence, and the benefits of chemotherapy are likely to be greater than the risks of side effects." ];
     fhir:CodeSystem.concept.definition [ fhir:value "Recurrence Score greater than or equal to 55: The cancer has a high risk of recurrence, and the benefits of chemotherapy are likely to be greater than the risks of side effects." ]
  ].

# - ontology header ------------------------------------------------------------

 a owl:Ontology;
  owl:imports fhir:fhir.ttl.